chinese tirzepatide Lilly's Weight-Loss Drug Approved in China Amid Race With Novo Tirzepatide Sheds Pounds in Chinese

Semaglu 1 Injection is a weekly GLP-1 medication for Type 2 diabetes and weight loss

Various components of MetS are investigated, including visceral obesity, dyslipidemia, elevated blood pressure, impaired fasting glucose, and insulin resistance

New studies show LDN quiets over-active immune cells, balances nervous-system signals, and resets hormones

PRINCETON, N.J., Dec

Semaglutide and tirzepatide are both GLP-1 medications for weight loss, but tirzepatide targets an additional hormone pathway, potentially offering stronger results for some patients seeking personalized treatment

Novartis ~$30B+ dealmaking to strengthen pipeline New drug launches driving growth Heavy investment in oncology + cardiovascular Trend: More capital more late-stage assets rising demand for clinical leadership